Vitamin D3 for Life

Live Enlightened

Article

Biological Noise in Vitamin D Testing: Physiological, Analytical and Population Variability: Evidence Synthesis

Previous related pageBiological Noise in Vitamin D TestingNext related pageChoosing the Correct Vitamin D Biomarker: Clinical Limitations and Misinterpretation Risks: Full Study
Study at a glance

Why can my vitamin D blood result change between tests?

The amount in your blood can genuinely change with season, sunlight, intake and health. Laboratory differences can also affect the reported number. A change can reflect either source, or both.

Does a small change in vitamin D mean my health has changed?

Not necessarily. Ordinary variation can move a result slightly above or below a cut-off without an equally sudden change in health. The size of the change and the circumstances of both tests matter.

Is vitamin D testing too variable to be useful?

No. A test provides useful information about vitamin D status at that time. Comparing results is easier when the laboratory method, time of year and changes in supplements or health are known.

Is a population vitamin D range the same as my personal range?

No. A population range describes many people with different circumstances. It does not show exactly how much one person’s level usually varies or establish that person’s ideal target.

Read the full article below ↓

A vitamin D blood result looks precise because it is expressed as a number, but that number sits at the intersection of several different sources of variability. The concentration of 25-hydroxyvitamin D, or 25(OH)D, genuinely changes within the same person. The laboratory method used to measure it can introduce additional imprecision or bias. The population against which a result is compared also varies according to season, geography, body composition, exposure patterns and other characteristics.

These sources of variation are often grouped together as “noise,” but they are not interchangeable. Seasonal change is real physiology. Assay bias is a measurement problem. Population heterogeneity is a property of the group being studied. Threshold classification can then amplify all three by turning a relatively small numerical difference into a different interpretive label.

The central lesson from the evidence is therefore not that vitamin D testing is unreliable. It is that a 25(OH)D result has to be interpreted as a measurement produced under particular biological, analytical and population conditions.

Three different kinds of variability affect the same vitamin D result

The first layer is physiological variability. A person’s circulating 25(OH)D concentration is not permanently fixed. It changes with season and can also vary over shorter periods. Body size, metabolic context and some physiological states can alter the concentration or its distribution.

The second layer is analytical variability. Different assays do not necessarily return identical values from comparable samples. Precision, calibration, bias and the ability to recover different vitamin D metabolites can all affect the reported result.

The third layer is population variability. Even when measurement is standardised, different populations have different distributions of 25(OH)D. Those distributions depend on factors such as season, latitude, sunlight exposure, diet, supplementation, body size and participant selection.

Separating these layers is essential. A difference between two vitamin D results may reflect genuine biological movement, laboratory measurement effects, or both. A result that appears unusual relative to one population may be less unusual in another. A value close to a cut-off can move between categories even when the underlying change is modest.

Season is the strongest predictable source of physiological variation

Seasonal variation is one of the most reproducible features of circulating 25(OH)D. In the Cardiovascular Health Study, 2,298 older adults showed a clear annual pattern. The estimated annual mean was 25.1 ng/mL, while the average peak-to-trough seasonal difference was 9.6 ng/mL.

That difference is large enough to matter when an individual result is interpreted near a numerical threshold. A concentration measured near the annual peak does not necessarily represent the concentration that would be found several months later near the annual trough.

The size of the seasonal change was also not identical across participants. Latitude, sex and physical activity were among the factors associated with the magnitude of the annual swing. This prevents a simple interpretation in which one universal seasonal correction is added to or subtracted from every result.

Season therefore creates structured biological variation rather than random instability. The wider annual pattern is developed in Seasonal Fluctuations in Vitamin D Levels.

Shorter-term biological variation is real but generally smaller

Repeat-measurement studies show that 25(OH)D also varies over shorter periods, but the scale is usually smaller than the seasonal effect.

In 160 participants measured twice about six weeks apart, Lutsey and colleagues reported a within-person coefficient of variation of 6.9 percent for total 25(OH)D. Repeat measurements correlated strongly. Viljoen and colleagues estimated within-person variation at 12.1 percent in a separate biological-variation study.

These findings matter because not every numerical difference between sequential tests represents a major change in vitamin D physiology. A modest shift can occur through ordinary biological variability, even when the laboratory method performs well.

At the same time, a single measurement is not meaningless. Longer-term repeat studies show substantial tracking between people. Individuals with relatively higher concentrations often remain relatively higher than others even though their exact numerical values change.

The appropriate interpretation is therefore between two extremes. 25(OH)D is not a permanent personal constant, but neither is it a randomly fluctuating value with no longitudinal information.

Time of day appears to matter less than season

Within-day variation has received particular attention because a circadian effect could theoretically make morning and afternoon samples difficult to compare. The evidence supports a measurable rhythm, but it also shows why the magnitude should not be exaggerated.

Jones and colleagues collected blood every four hours across 24 hours from older adults in the United Kingdom, The Gambia and China. Significant diurnal rhythms were detected in total 25(OH)D, vitamin D-binding protein, albumin and free vitamin D metabolites.

A more tightly controlled 2026 study by Bishop and colleagues placed 67 healthy adults in conditions designed to minimise external vitamin D influences. Participants were shielded from sunlight, consumed standardised meals without vitamin D and underwent repeated serum calcifediol measurements across 24 hours using LC-MS/MS.

A statistically detectable circadian rhythm was present, but its amplitude was only 0.19 ng/mL around an average concentration of approximately 21.5 ng/mL. Within-person variation was 5.54 percent, only modestly greater than the assay precision reported in the study.

This newer controlled evidence places an important boundary around the older diurnal findings. Time of day can contribute to variation, but the available evidence does not support the assumption that intrinsic 25(OH)D concentrations normally undergo large hour-to-hour swings.

The physiological evidence is examined in greater depth in Physiological Variability in Vitamin D Measurements: Seasonal, Diurnal and Metabolic Effects: Full Study.

Analytical noise is a different problem

Biological variability can occur even when the assay is functioning correctly. Analytical variability begins when the measurement process itself affects the reported value.

The Vitamin D Standardization Program was developed because 25(OH)D results from different assays and laboratories were not sufficiently comparable. A major intralaboratory investigation by Wise and colleagues compared 13 assays against reference measurement values using 50 individual-donor serum samples.

All 13 assays met the study’s overall precision criterion, but only nine met the mean-bias criterion. This distinction is fundamental. A measurement system can repeatedly produce similar values while those values remain systematically displaced from the reference measurement.

Across the donor samples, the NIST reference mean was 77.1 nmol/L, while assay means ranged from 69.0 to 93.3 nmol/L. The difference is large enough to become important when a result lies close to a diagnostic or interpretive boundary.

Vitamin D2 can expose method-specific bias

Assay disagreement is not always a simple fixed offset. In the VDSP comparison, samples containing relatively high concentrations of 25(OH)D2 revealed additional differences between analytical systems. Ten immunoassays changed their response in the presence of high 25(OH)D2, while other methods were less affected.

This matters because total 25(OH)D is expected to reflect both 25(OH)D2 and 25(OH)D3. If an assay recovers the two metabolites differently, the size of the error can depend on the composition of an individual’s sample rather than being identical for everyone tested by that laboratory.

This also demonstrates why “analytical noise” should not be treated as one universal percentage. It can contain random imprecision, systematic bias and sample-dependent effects.

Laboratory differences can change the apparent diagnosis

Earlier interlaboratory studies demonstrated how strongly method differences could affect interpretation. Binkley and colleagues divided samples from the same healthy adults between multiple laboratories. Mean measured concentrations across six laboratories ranged from 17.1 to 35.6 ng/mL.

Results that far apart can place the same underlying biological sample into very different interpretive categories. The problem becomes particularly visible when a threshold is used to divide a continuous measurement into categories such as deficient, insufficient or sufficient.

A result far from a threshold may remain in the same category despite moderate measurement error. A result close to the boundary may change classification after a much smaller movement. Thresholds therefore amplify both analytical and biological variability.

Population estimates can also be distorted by assay calibration

Analytical effects are not limited to the interpretation of one person’s blood test. When thousands of measurements are combined, assay bias can change estimates of how common low vitamin D status appears to be in a population.

In the Irish National Adult Nutrition Survey, Cashman and colleagues compared original ELISA-derived measurements with values adjusted using Vitamin D Standardization Program procedures and with reanalysis by standardised LC-MS/MS.

The estimated prevalence below 30 nmol/L was 6.5 percent using the original ELISA results. After standardisation it was 11.4 percent, while LC-MS/MS reanalysis produced 11.2 percent. At a 50 nmol/L threshold, the corresponding estimates were 40.0, 43.7 and 45.0 percent.

The participants did not biologically change during this comparison. What changed was the analytical interpretation of the stored samples. This demonstrates how measurement bias can alter apparent public-health prevalence.

Standardisation improves comparability but does not remove biological heterogeneity

Standardisation addresses the analytical layer by making results more traceable to common reference procedures. It cannot make biologically different populations identical.

Even perfectly standardised measurements will still vary across populations because the people being measured differ. Sun exposure, season, latitude, diet, supplementation, body size, age and other characteristics affect the distribution of circulating 25(OH)D.

This means that population variability remaining after analytical standardisation should not be described as laboratory error. Much of it is genuine biological and environmental heterogeneity.

Why population reference ranges need context

A laboratory reference interval describes the distribution observed in a defined reference population under defined conditions. That is not automatically the same thing as a biological optimum, a treatment threshold or an individual’s expected personal range.

Biological-variation analysis illustrates the problem. Viljoen and colleagues estimated between-person variation of 40.3 percent compared with within-person variation of 12.1 percent. Their calculated index of individuality was low.

When between-person variation is much greater than within-person variation, a broad population interval may contain substantial variation that is irrelevant to judging whether one person’s result has changed meaningfully from their own previous pattern.

Population reference intervals still have a legitimate role, but they answer a population question. Their interpretation is developed further in Population Reference Ranges Explained.

Season also changes the reference population

Season affects more than repeated measurements within an individual. It shifts the distribution of 25(OH)D across whole populations.

This creates an interaction between physiological and population-level variability. A reference population sampled mainly during summer can have a different distribution from one sampled during winter even if the laboratory method is identical.

Reference-interval studies have found higher population distributions during summer and have also shown that different methods for selecting the reference population can produce different intervals. These findings do not identify one universally correct range. They show that population definition and season are part of the range’s meaning.

LC-MS/MS reduces some problems but does not eliminate measurement uncertainty

Liquid chromatography tandem mass spectrometry is valuable because it can distinguish 25(OH)D2 from 25(OH)D3 and can achieve strong analytical performance. However, the method name alone does not guarantee accuracy.

Calibration, extraction procedures, chromatographic separation, internal standards, traceability and laboratory quality control still determine whether a measurement is reliable. Variation has been documented between laboratories using mass-spectrometric methods as well as between immunoassays.

The useful distinction is therefore not simply immunoassay versus LC-MS/MS. It is whether the analytical method demonstrates appropriate performance and traceability for the measurand being reported.

What happens when the different sources of noise overlap?

The greatest interpretive difficulty occurs when several forms of variability operate at once.

Consider two measurements taken from the same person several months apart. The second result may differ because the season changed. The person’s physiology or vitamin D exposure may also have changed. The two samples may have been analysed by different assays. If the values sit near a threshold, a modest combined difference can then produce a different categorical label.

None of those possibilities proves that the first or second measurement is wrong. They show why an isolated numerical difference cannot always reveal its own cause.

The analytical and population evidence is examined in depth in Analytical and Population-Level Noise in Vitamin D Test Interpretation: Full Study.

What standardisation can and cannot solve

Standardisation is one of the most important responses to vitamin D measurement variability because it reduces avoidable disagreement between laboratories and methods. It improves the comparability of individual measurements, epidemiological studies and trends measured over time.

But standardisation cannot eliminate seasonality. It cannot remove genuine metabolic differences between people. It cannot make one reference population representative of every other population. It cannot prevent a continuous value close to a threshold from moving across that threshold after a small genuine biological change.

Standardisation therefore solves part of the problem rather than the whole problem.

Why one vitamin D result should not be treated as an immutable personal characteristic

A single 25(OH)D result can be clinically and scientifically useful. The evidence does not support dismissing it as meaningless noise. However, it is still a time-specific measurement.

The date of collection matters because of season. The interval from previous testing matters because of normal within-person variation. The assay and laboratory matter because of analytical performance. The population against which a result is interpreted matters because population distributions are context-dependent.

This broader distinction between real biological movement and measurement variability is central to Variability in Vitamin D Measurements.

What the combined evidence establishes

The evidence establishes that biological, analytical and population variability all contribute to the interpretation of vitamin D measurements, but they do so through different mechanisms.

Physiological variability: 25(OH)D genuinely changes within people. Season is the strongest predictable temporal influence in the available evidence. Shorter-term variability is usually smaller. Intrinsic circadian variation can be detected but appears modest under controlled conditions.

Analytical variability: assay precision does not guarantee accuracy. Different methods can have different biases, and some respond differently to 25(OH)D2. These effects can alter individual classifications and population prevalence estimates.

Population variability: even standardised measurements differ widely between people and populations because the underlying biology and exposures differ. Reference intervals therefore remain dependent on how, when and in whom they were derived.

Threshold effects: categorical interpretation can magnify relatively small biological or analytical differences when a measurement lies close to a cut-off.

What the combined evidence does not establish

The evidence does not establish that vitamin D testing is too noisy to be useful. It does not show that every change between two measurements is caused by laboratory error. It does not establish that season or time of day can be corrected with one universal formula. It does not show that LC-MS/MS is automatically accurate without standardisation and quality control.

It also does not establish that population reference intervals are meaningless. It establishes that they describe a particular population distribution and should not automatically be converted into universal individual biological targets.

Final interpretation

Biological noise in vitamin D testing is best understood as several overlapping sources of variability rather than one vague measurement problem. Season and other physiological influences can move the concentration genuinely present in the blood. Analytical methods can alter how faithfully that concentration is reported. Population characteristics determine the distribution against which the number is compared.

The result remains useful when those layers are kept distinct. The strongest interpretation is therefore not “the vitamin D level is the number” or “the number cannot be trusted.” It is that a 25(OH)D measurement is an informative but context-dependent observation whose meaning depends on physiology, analytical performance and the population framework used to interpret it.

Primary sources and publication details

Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the Cardiovascular Health Study. American Journal of Epidemiology. 2011;174(12):1363-1372. PMID: 22112344. Read the full study.

Lutsey PL, Parrinello CM, Misialek JR, et al. Short-term variability of vitamin D-related biomarkers. Clinical Chemistry. 2016;62(12):1647-1653. PMID: 27694392. Read the full study.

Jones KS, Redmond J, Fulford AJ, et al. Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites. Journal of Steroid Biochemistry and Molecular Biology. 2017;172:130-135. PMID: 28732681. Read the full study.

Bishop CW, Choe J, Strugnell SA, et al. Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity. Journal of Steroid Biochemistry and Molecular Biology. 2026;256:106897. PMID: 41238065. Read the full study.

Viljoen A, Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. Journal of Clinical Laboratory Analysis. 2011;25(2):130-133. PMID: 21438007. Read the full study.

Major JM, Graubard BI, Dodd KW, et al. Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. Journal of Clinical Endocrinology and Metabolism. 2013;98(1):97-104. PMID: 23144464. Read the full study.

Wise SA, Camara JE, Sempos CT, et al. Vitamin D Standardization Program (VDSP) intralaboratory study for the assessment of 25-hydroxyvitamin D assay variability and bias. Journal of Steroid Biochemistry and Molecular Biology. 2021;212:105917. PMID: 34010687. Read the full study.

Hyppönen E, Turner S, Cumberland P, Power C, Gibb I. Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. Journal of Clinical Endocrinology and Metabolism. 2007;92(12):4615-4622. PMID: 17726070. Read the study record.

Cashman KD, Kiely M, Kinsella M, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program’s potential for national nutrition and health surveys. American Journal of Clinical Nutrition. 2013. Read the full study.

Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. Journal of Clinical Endocrinology and Metabolism. 2004;89(7):3152-3157. PMID: 15240586. Read the study record.

Related reading

Original sources

Source

Read the full study

Shoben AB, Kestenbaum B, Levin G, et al.

Publication details

Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the Cardiovascular Health Study. American Journal of Epidemiology. 2011;174(12):1363-1372. PMID: 22112344. Read the full study.

Read more →
Source

Read the full study

Lutsey PL, Parrinello CM, Misialek JR, et al.

Publication details

Lutsey PL, Parrinello CM, Misialek JR, et al. Short-term variability of vitamin D-related biomarkers. Clinical Chemistry. 2016;62(12):1647-1653. PMID: 27694392. Read the full study.

Read more →
Source

Read the full study

Bishop CW, Choe J, Strugnell SA, et al.

Publication details

Bishop CW, Choe J, Strugnell SA, et al. Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity. Journal of Steroid Biochemistry and Molecular Biology. 2026;256:106897. PMID: 41238065. Read the full study.

Read more →
Source

Read the full study

Viljoen A, Singh DK, Farrington K, Twomey PJ.

Publication details

Viljoen A, Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. Journal of Clinical Laboratory Analysis. 2011;25(2):130-133. PMID: 21438007. Read the full study.

Read more →
Source

Read the full study

Major JM, Graubard BI, Dodd KW, et al.

Publication details

Major JM, Graubard BI, Dodd KW, et al. Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. Journal of Clinical Endocrinology and Metabolism. 2013;98(1):97-104. PMID: 23144464. Read the full study.

Read more →
Source

Read the full study

Wise SA, Camara JE, Sempos CT, et al.

Publication details

Wise SA, Camara JE, Sempos CT, et al. Vitamin D Standardization Program (VDSP) intralaboratory study for the assessment of 25-hydroxyvitamin D assay variability and bias. Journal of Steroid Biochemistry and Molecular Biology. 2021;212:105917. PMID: 34010687. Read the full study.

Read more →
Source

Read the study record

Hyppönen E, Turner S, Cumberland P, Power C, Gibb I.

Publication details

Hyppönen E, Turner S, Cumberland P, Power C, Gibb I. Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. Journal of Clinical Endocrinology and Metabolism. 2007;92(12):4615-4622. PMID: 17726070. Read the study record.

Read more →
Source

Read the full study

Cashman KD, Kiely M, Kinsella M, et al.

Publication details

Cashman KD, Kiely M, Kinsella M, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program’s potential for national nutrition and health surveys. American Journal of Clinical Nutrition. 2013. Read the full study.

Read more →
Source

Read the study record

Binkley N, Krueger D, Cowgill CS, et al.

Publication details

Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. Journal of Clinical Endocrinology and Metabolism. 2004;89(7):3152-3157. PMID: 15240586. Read the study record.

Read more →